Transplantation Society
Public records show a registered, tax-exempt organization in good standing.
What it says it does
THE TRANSPLANTATION SOCIETY PROVIDES THE FOCUS FOR GLOBAL LEADERSHIP IN TRANSPLANTATION FOR THE DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE, SCIENTIFIC COMMUNICATION, CONTINUING EDUCATION AND GUIDANCE ON THE ETHICAL PRACTICE.
- Income
- $4.9 million
- Spending
- $4.5 million
- Spent on programs
- 74%
- Reserves
- 30 months of spending
- Largest source of income
- fees for its services, 70%
- Employees
- 0
- Volunteers
- 87
- Highest pay
- $131,422, executive director
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 100 out of 100. Higher than 83% of charities in its peer group (diseases, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 30.0 months of spending.
Debt
20 of 20It owes 9% of what it owns.
Living within its means
15 of 15Income exceeded spending by 8% of income.
Income trend
15 of 15Income rose 102% on the year before.
Spending floor
15 of 1574% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Good: 85 out of 100. Higher than 33% of charities in its peer group (diseases, $1m to $10m).
Independent board
25 of 2521 of 21 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
0 of 8Reports no written whistleblower policy.
Record keeping policy
0 of 7Reports no written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (4)
- $2.1 million spent. EVENTS HELD IN A VARIETY OF GLOBAL VENUES WHERE MEMBERS OF THE COMMUNITY ARE BROUGHT TOGETHER TO DISCUSS ADVANCEMENTS IN ORGAN TRANSPLANTATION. ORGAN TRANSPLANTATION IS A SUCCESSFUL THERAPY FOR END STAGE ORGAN FAILURE OF THE KIDNEY, LIVER, HEART, LUNG, PANCREAS AND INTESTINE. TRANSPLANTATION OF CELLS AND TISSUES ALSO TRANSFORMED THE THERAPEUTIC OPTIONS FOR PATIENTS WITH MALIGNANT HAEMATOLOGICAL DISEASE, EYE DISEASE AND ORTHOPAEDIC DISEASE, AND HAS THE POTENTIAL TO ALTER SIGNIFICANTLY THE THERAPEUTIC OPTIONS FOR PATIENTS WITH DIABETES AND A RANGE OF DISORDERS. THE ACCESS OF PATIENTS TO TRANSPLANTATION THERAPY VARIES WIDELY ACROSS THE GLOBE, PARTLY DETERMINED BY THE UNDERLYING LEVEL OF ECONOMIC DEVELOPMENT IN DIFFERENT STATES AND PARTLY DETERMINED BY OTHER FACTORS SUCH AS THE AVAILABILITY OF ORGAN, CELL AND TISSUE DONORS, OR THE SPECIALIZED PROVISION OF HEALTH SERVICES. THE ORGANIZATION HAS DETERMINED THAT IT WILL SEEK TO ADDRESS GLOBAL INEQUITIES IN TRANSPLANTATION THERAPY, IN ORDER TO FACILITATE APPROPRIATE ACCESS TO TRANSPLANTATION FOR ALL PATIENTS WHO WOULD BENEFIT. (Expenses $ 48,304 including grants of $ 0)(Revenue $ 0) Other
- $662,549 spent. PROGRAM AND MAGAZINE PUBLICATIONS INCLUDING WEBSITE DEVELOPMENT AND WEBINARS AVAILABLE TO MEMBERS ONLY. THESE PUBLICATIONS RELATE SPECIFICALLY TO THE FIELD OF ORGAN TRANSPLANTATION.
- $523,924 spent. AN INTERNATIONAL FORUM FOR THE WORLD-WIDE ADVANCEMENT OF ORGAN TRANSPLANTATION INCLUDING A FOCUS ON - DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE - SCIENTIFIC COMMUNICATION - CONTINUING EDUCATION - GUIDANCE ON THE ETHICAL PRACTICE OF TRANSPLANTATION. THE ORGANIZATION ACHIEVES THIS FOCUS BY MAKING GRANTS TO SECTION AND REGIONAL SOCIETIES FOR THE PURPOSE OF TRAVEL, RESEARCH FELLOWSHIP, AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. THE PRIMARY AWARDS AND GRANTS ARE: 1) THE MEDAWAR PRIZE, NAMED AFTER SOCIETY CO-FOUNDER SIR PETER MEDAWAR, IS RECOGNIZED AS THE WORLD'S HIGHEST DEDICATED AWARD FOR THE MOST OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION. THE MEDAWAR PRIZE HAS BEEN AWARDED TO TWO OR MORE RECIPIENTS AT EACH OF THE ORGANIZATION'S BIENNIAL CONGRESSES SINCE 1990. THE AWARD IS MADE POSSIBLE BY A GENEROUS GRANT FROM NOVARTIS PHARMA AG WHO AGREED THAT A PRESTIGIOUS PRIZE BE ESTABLISHED AND MAINTAINED TO RECOGNIZE THE OUTSTANDING INVESTIGATORS WHOSE CONTRIBUTIONS HAVE HAD SUCH A PROFOUND INFLUENCE ON THE FIELD OF ORGAN TRANSPLANTATION. 2) TTS Thomas Starzl Innovation Award. Named after Tom Starzl who was best known for his contributions to the field of organ transplantation, and often referred to as the "father of transplantation". The award recognizes individuals who, though advanced and original work, have contributed significantly to transplantation, thereby reflecting the spirit pioneered by Dr. Starzl. 3) TTS RESEARCH FELLOWSHIPS ARE OFFERED FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT OF A FULL TTS MEMBER. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 4) TRAVEL GRANTS FOR YOUNG INVESTIGATORS AND FOR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION. (Expenses $ 48,304 including grants of $ 0)(Revenue $ 0) Other
- $48,304 spent. Other
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since February 1974.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.